Patritumab (Anti-ERBB3 / HER3)
Product Specifications
CAS Number
1262787-83-6
Synonyms
Human Anti-ERBB3 Recombinant Antibody
SKU
C00305-1mg
Target
HER2
Applications
Protein Tyrosine Kinase
Additionnal Information
Patritumab (Anti-ERBB3 / HER3) is a neutralizing monoclonal antibody targeting ERBB3. Patritumab shows a synergy with Cetuximab, potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ICH5121-10mg 10 mg (2x 5 mg)
Necitumumab Biosimilar - Research Grade
Sign In for Pricing
View Details 
PKSM041396-01 10 µg
Recombinant Human IL-23 alpha & Mouse IL-12 beta Heterodimer (C-6His)
Sign In for Pricing
View Details PKSM041396-02 50 µg
Recombinant Human IL-23 alpha & Mouse IL-12 beta Heterodimer (C-6His)
Sign In for Pricing
View Details